Literature DB >> 18541653

Specific roles of the iroBCDEN genes in virulence of an avian pathogenic Escherichia coli O78 strain and in production of salmochelins.

Mélissa Caza1, François Lépine, Sylvain Milot, Charles M Dozois.   

Abstract

Avian pathogenic Escherichia coli (APEC) strains are a subset of extraintestinal pathogenic E. coli (ExPEC) strains associated with respiratory infections and septicemia in poultry. The iroBCDEN genes encode the salmochelin siderophore system present in Salmonella enterica and some ExPEC strains. Roles of the iro genes for virulence in chickens and production of salmochelins were assessed by introducing plasmids carrying different combinations of iro genes into an attenuated salmochelin- and aerobactin-negative mutant of O78 strain chi7122. Complementation with the iroBCDEN genes resulted in a regaining of virulence, whereas the absence of iroC, iroDE, or iroN abrogated restoration of virulence. The iroE gene was not required for virulence, since introduction of iroBCDN restored the capacity to cause lesions and colonize extraintestinal tissues. Prevalence studies indicated that iro sequences were associated with virulent APEC strains. Liquid chromatography-mass spectrometry analysis of supernatants of APEC chi7122 and the complemented mutants indicated that (i) for chi7122, salmochelins comprised 14 to 27% of the siderophores present in iron-limited medium or infected tissues; (ii) complementation of the mutant with the iro locus increased levels of glucosylated dimers (S1 and S5) and monomer (SX) compared to APEC strain chi7122; (iii) the iroDE genes were important for generation of S1, S5, and SX; (iv) iroC was required for export of salmochelin trimers and dimers; and (v) iroB was required for generation of salmochelins. Overall, efficient glucosylation (IroB), transport (IroC and IroN), and processing (IroD and IroE) of salmochelins are required for APEC virulence, although IroE appears to serve an ancillary role.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18541653      PMCID: PMC2493193          DOI: 10.1128/IAI.00455-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC.

Authors:  T A Russo; J R Johnson
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

2.  Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of uropathogenic Escherichia coli strain 536.

Authors:  Ulrich Dobrindt; Gabriele Blum-Oehler; Gabor Nagy; György Schneider; André Johann; Gerhard Gottschalk; Jörg Hacker
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli.

Authors:  R A Welch; V Burland; G Plunkett; P Redford; P Roesch; D Rasko; E L Buckles; S-R Liou; A Boutin; J Hackett; D Stroud; G F Mayhew; D J Rose; S Zhou; D C Schwartz; N T Perna; H L T Mobley; M S Donnenberg; F R Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-05       Impact factor: 11.205

4.  TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse.

Authors:  A G Torres; P Redford; R A Welch; S M Payne
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.

Authors:  Thomas A Russo; Catherine D McFadden; Ulrike B Carlino-MacDonald; Janet M Beanan; Travis J Barnard; James R Johnson
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli).

Authors:  Richard J Bauer; Lixin Zhang; Betsy Foxman; Anja Siitonen; Maria E Jantunen; Harri Saxen; Carl F Marrs
Journal:  J Infect Dis       Date:  2002-04-30       Impact factor: 5.226

7.  The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition.

Authors:  David H Goetz; Margaret A Holmes; Niels Borregaard; Martin E Bluhm; Kenneth N Raymond; Roland K Strong
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

8.  Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917.

Authors:  Marianne Valdebenito; Alvin L Crumbliss; Günther Winkelmann; Klaus Hantke
Journal:  Int J Med Microbiol       Date:  2006-09-27       Impact factor: 3.473

Review 9.  Iron metabolism in pathogenic bacteria.

Authors:  C Ratledge; L G Dover
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

10.  Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections.

Authors:  Sören Schubert; Bertrand Picard; Stéphanie Gouriou; Jürgen Heesemann; Erick Denamur
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more
  37 in total

1.  A metabolic operon in extraintestinal pathogenic Escherichia coli promotes fitness under stressful conditions and invasion of eukaryotic cells.

Authors:  Géraldine Rouquet; Gaëlle Porcheron; Claire Barra; Maryline Répérant; Nathalie K Chanteloup; Catherine Schouler; Philippe Gilot
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

2.  Transcriptome analysis of avian pathogenic Escherichia coli O1 in chicken serum reveals adaptive responses to systemic infection.

Authors:  Ganwu Li; Kelly A Tivendale; Peng Liu; Yaping Feng; Yvonne Wannemuehler; Wentong Cai; Paul Mangiamele; Timothy J Johnson; Chrystala Constantinidou; Charles W Penn; Lisa K Nolan
Journal:  Infect Immun       Date:  2011-02-28       Impact factor: 3.441

Review 3.  Targeting iron assimilation to develop new antibacterials.

Authors:  Timothy L Foley; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2012-07-19       Impact factor: 6.098

4.  Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2.

Authors:  Michael A Bachman; Jennifer E Oyler; Samuel H Burns; Mélissa Caza; François Lépine; Charles M Dozois; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

5.  The ssbL gene harbored by the ColV plasmid of an Escherichia coli neonatal meningitis strain is an auxiliary virulence factor boosting the production of siderophores through the shikimate pathway.

Authors:  Chloé Lemaître; Philippe Bidet; Jean-François Benoist; Dimitri Schlemmer; Elsa Sobral; Camille d'Humières; Stéphane Bonacorsi
Journal:  J Bacteriol       Date:  2014-01-17       Impact factor: 3.490

6.  Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes.

Authors:  Tony D Davis; Poornima Mohandas; Maria I Chiriac; Glennon V Bythrow; Luis E N Quadri; Derek S Tan
Journal:  Bioorg Med Chem Lett       Date:  2016-09-16       Impact factor: 2.823

7.  Characterization of the contribution to virulence of three large plasmids of avian pathogenic Escherichia coli chi7122 (O78:K80:H9).

Authors:  Melha Mellata; Keith Ameiss; Hua Mo; Roy Curtiss
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 8.  Th17 cytokines and the gut mucosal barrier.

Authors:  Christoph Blaschitz; Manuela Raffatellu
Journal:  J Clin Immunol       Date:  2010-02-02       Impact factor: 8.317

9.  SodA Contributes to the Virulence of Avian Pathogenic Escherichia coli O2 Strain E058 in Experimentally Infected Chickens.

Authors:  Qingqing Gao; Le Xia; Xiaobo Wang; Zhengqin Ye; Jinbiao Liu; Song Gao
Journal:  J Bacteriol       Date:  2019-02-25       Impact factor: 3.490

10.  Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin.

Authors:  Michael A Bachman; Virginia L Miller; Jeffrey N Weiser
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.